NSA against three for selling COVID drug at higher rates

Recovered injections do not have any batch number or other details, says UP STF

April 17, 2021 01:27 am | Updated 01:27 am IST - LUCKNOW

The police in U.P.’s Kanpur have said they will slap the National Security Act (NSA) against three persons who were arrested on charges of allegedly smuggling and selling Remdesivir, an injectable drug used in the treatment of COVID-19, at rates higher than in the market.

The arrests come two days after the State government urgently procured 25,000 vials of the drug from Gujarat due to the rise in number of cases and demand for the drug.

In Kanpur, the U.P. Special Task Force, said they recovered 265 vials of Covifor injection (Remdesivir) which the accused persons were smuggling at a higher rate.

The action came after intelligence inputs, stating that since there was a shortage of Remdesivir in local markets, “drug smugglers” were selling it at a much higher price, the UP STF, which carried out the operation, said.

The recovered injections, which cost around ₹5,400 each did not have any batch number or other details, the STF said.

Aseem Arun, Police Commisioner (Kanpur), said the stringent NSA would be lodged against the accused as “it was a crime against humanity”.

The police were trying to identify all those involved in the sourcing and trade of the drugs, he said in a tweet shared by Kanpur police.

The arrested persons were identified as Mohan Soni, Prashant Shukla and Sachin Kumar. Soni and Shukla are medical representatives, the STF said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.